SEC Comment Letter for Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Nov 16, 2017
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Nov. 16, 2017 · CIK: 0001279704 · Accession: 0000000000-17-040604
AI Filing Summary & Sentiment
Reasoning
Letter
November 16, 2017 James V. Caruso Chief Executive Officer Cellectar Biosciences, Inc. 3301 Agriculture Drive Madison, WI 53716 Cellectar Biosciences, Inc. Registration Statement on Form S-1 Filed November 9, 2017 File No. 333-221468Re: Dear Mr. Caruso: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Gregory J. Lynch
Show Raw Text
November 16, 2017
James V. Caruso
Chief Executive Officer
Cellectar Biosciences, Inc.
3301 Agriculture Drive
Madison, WI 53716
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed November 9, 2017
File No. 333-221468Re:
Dear Mr. Caruso:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Gregory J. Lynch